One BR one bath 384 square feet. Sale pending is contingent so you can still make an offer. Here’s the listing: https://www.realtor.com/realestateandhomes-detail/10036-Carmen-Rd_Cupertino_CA_95014_M19549-12789
WTF
A Lego Lesson in Perceived Value
We recently took a trip to Texas with a trunk load full of old Legos to a Lego store that buys and sells Legos. Our entire intent was to de-clutter and get rid of some old sets and extra pieces. We were ready to donate the stuff. Give it away to Goodwill or another charity.
Well…

A Goodwill in Pennsylvania just sold a rare 14-karat gold Lego piece for $18,101.
Goodwill Listed This Rare Gold Lego Piece for $14.95. It Sold for $18,101 — https://www.smithsonianmag.com/smart-news/rare-gold-lego-piece-found-at-goodwill-sells-for-18101-180983913
But I Lost 25 pounds!
The recent analysis in JAMA focused on serious stomach disorders and GLP-1 agonists.
Researchers in Canada compared safety outcomes for GLP-1 agonists and bupropion-naltrexone, an older class of weight-loss medication. The retrospective analysis included 4144 people with obesity who were prescribed liraglutide, 613 prescribed semaglutide, and 654 prescribed the older treatment. People with a diabetes code in their health record were excluded from the study.
The GLP-1 group had a 9 times greater risk of pancreatitis, a 4 times greater risk of bowel obstruction, and a more than 3 times greater risk of gastroparesis, which causes stomach paralysis. The absolute risks in the GLP-1 group, however, were all about 1% or less per year of GLP-1 use. And semaglutide and liraglutide were not associated with biliary disease, which affects the gallbladder and bile production.
As Semaglutide’s Popularity Soars, Rare but Serious Adverse Effects Are Emerging — https://jamanetwork.com/journals/jama/fullarticle/2812192
Sorry, but as a reasonably normal human who lost >200 pounds without surgery or drugs I just don’t get it. We all want the easy way out I guess.
The Dark Side of TikTok – Financial Advice?
The TikToker touting “generational wealth” isn’t alone in promoting the benefits of slapping a child’s name onto credit card debts. TikTok is flooded with influencers who insist that authorizing minors to use their parents or older relatives’ credit cards will set them up for a bright future.
Many of the videos uploaded to the platform are captioned with the hashtag #generationalwealth and suggest that the authorized credit card user trick is a secret hack used by the wealthy.
‘Generational wealth’ influencers are touting the benefits of parents adding their kids to credit card debt—but experts warn it could go badly wrong — https://fortune.com/2023/10/21/building-generational-wealth-parents-children-credit-card-debt/
Parents, don’t do this. TikTok should not be your source for financial advice.
Instead teach your children to save and invest, to live within their means, to understand the difference between needs and wants, to not become an indentured servant to the banking industry.
The Dark Side of Tik Tok – Soak Your Eyeballs in Castor Oil
Some people on TikTok have been telling you to rub castor oil around and potentially into your eyes, even though it’s approved by the Food and Drug Administration (FDA) as a laxative and not as an eye remedy. TikTokers have been claiming that castor oil can help treat all sorts of eye problems ranging from eye dryness to floaters to cataracts to poor vision to glaucoma.
TikTokers Push Castor Oil As An Eye Remedy, Here Are The Problems — https://www.forbes.com/sites/brucelee/2023/08/12/tiktokers-push-castor-oil-as-an-eye-remedy-here-are-the-problems/?sh=1111bfa485ce
Natural selection at its finest. And we thought drinking detergent was bad. The Dark Side of Tik Tok – Updated
The Dark Side of Tik Tok – Updated
In the latest health fad to alarm and exasperate medical experts, people on TikTok have cheerily “hopped on the borax train” and are drinking and soaking in the toxic cleaning product based on false claims that it can reduce inflammation, treat arthritis, and “detoxify” the body.
Borax is the new Tide Pods, and poison control experts are facepalming — https://arstechnica.com/health/2023/07/borax-is-the-new-tide-pods-and-poison-control-experts-are-facepalming/?comments=1&comments-page=1
Natural selection at its finest.
Good article on Vox. Why TikTokers are drinking laundry detergent https://www.vox.com/technology/2023/7/29/23811639/tiktok-borax-challenge-dangerous-laundry-detergent
New Wonder Drug! Treat Diabetes, Obesity AND Addiction – (yup another GLP-1 receptor agonist post)
Previous research has found that activating GLP-1 receptors in rats’ brain causes the animals to eat less of a high-sugar chow, which they would normally prefer over a less delicious but healthier bland meal when given the option. This suggests that GLP-1 makes unhealthy food less rewarding. Schmidt’s team found the same to be true with cocaine: rats that received a GLP-1 agonist took less cocaine when it was offered. The researchers are now repeating the experiments in rats addicted to opioids or fentanyl. Several other studies have shown that GLP-1 agonists cause rats to drink less alcohol and produce less dopamine when they do drink, suggesting that the activity is no longer as pleasurable.
…it’s too early to say whether people recovering from addiction would need to take an GLP-1 agonist for the rest of their lives, like people with diabetes do, or whether these drugs could be short-term treatments that curb cravings long enough for people to make lifestyle changes to stay sober. People who stop taking semaglutide for weight loss quickly gain the weight back, and study animals that stop taking it return to alcohol and drug use, but “I don’t think we know enough yet” in humans, Simmons says.
Could New Weight-Loss Drugs like Ozempic Treat Addiction? — https://www.scientificamerican.com/article/could-new-weight-loss-drugs-like-ozempic-treat-addiction1/
The rest of this post is a repost of April Fools 2023 (this is a GLP-1 receptor agonist post). Enjoy!
Ozempic and a similar drug, Wegovy, are weekly shots you give yourself that cause the body to produce insulin. Insulin lowers blood sugar, slows digestion and makes people feel full. Carter-Williams tried it and was amazed.
“You are not hungry,” she says. “Like, I actually have to set timers to make sure that I do eat, because otherwise you actually forget to eat.”
‘You forget to eat’: How Ozempic went from diabetes medicine to blockbuster diet drug https://www.npr.org/2023/04/01/1166781510/ozempic-weight-loss-drug-big-business
Everyone wants the easy way out. I sometimes forget to eat but not because of a miracle drug. You wonder if those of us wanting to lose weight know you can’t stop taking this drug once you start it.
Patients discontinuing the use of weight-loss drugs such as Wegovy risk regaining their original body weight in about five years, a Novo Nordisk official said on Wednesday.
Novo Nordisk Says Stopping Obesity Drug May Cause Full Weight Regain in 5 Years–https://www.medscape.com/viewarticle/990267?src=rss
Side effects?
Just a few https://www.wegovy.com/taking-wegovy/side-effects.html
- Possible thyroid tumors, including cancer.
- Inflammation of your pancreas (pancreatitis)
- Gallbladder problems
- Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin
- Kidney problems (kidney failure)
- Serious allergic reactions
- Change in vision in people with type 2 diabetes.
- Increased heart rate
- Depression or thoughts of suicide.
So if you want to lose weight by taking a GLP-1 receptor agonist remember the risks of side effects including the real possibility of having to take a drug that costs up to $1600.00 a month for the rest of your life.
Good luck with that.
As an FYI this drug class is being investigated by the EU for a small number of cases reporting suicidal ideation https://www.latimes.com/business/story/2023-07-10/ozempic-weight-loss-drugs-probed-over-reports-of-suicidal-thoughts.
But we already knew this.
Why People Stop Using Drugs Like Ozempic – Wired (yet another GLP-1 receptor agonist post)
One study looked at GLP-1 RAs prescribed in the UK between 2009 and 2017. Out of the 589 patients who started taking a GLP-RA, 45 percent stopped taking the drug within 12 months, and 65 percent within 24 months. The same group of scientists also looked at people taking GLP-1 RAs in the US across a similar period of time. That study included a much larger group of diabetes patients but found that people quit taking the drugs at a similar rate as in the UK. Within 12 months, 47 percent of patients stopped taking their GLP-1 AR; after 24 months that figure was 70 percent. On average, people in that study spent around 13 months using the drug before they stopped taking it.
Why People Stop Using Drugs Like Ozempic —https://www.wired.com/story/ozempic-wegovy-quitting-weight-loss/?utm_source=pocket-newtab
For my last GLP-1 RA post see Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes — https://doi.org/10.2337/dc22-1710
To reduce the number of clicks the rest of this post is a repost of April Fools 2023 (this is a GLP-1 receptor agonist post). Enjoy!
Ozempic and a similar drug, Wegovy, are weekly shots you give yourself that cause the body to produce insulin. Insulin lowers blood sugar, slows digestion and makes people feel full. Carter-Williams tried it and was amazed.
“You are not hungry,” she says. “Like, I actually have to set timers to make sure that I do eat, because otherwise you actually forget to eat.”
‘You forget to eat’: How Ozempic went from diabetes medicine to blockbuster diet drug https://www.npr.org/2023/04/01/1166781510/ozempic-weight-loss-drug-big-business
Everyone wants the easy way out. I sometimes forget to eat but not because of a miracle drug. You wonder if those of us wanting to lose weight know you can’t stop taking this drug once you start it.
Patients discontinuing the use of weight-loss drugs such as Wegovy risk regaining their original body weight in about five years, a Novo Nordisk official said on Wednesday.
Novo Nordisk Says Stopping Obesity Drug May Cause Full Weight Regain in 5 Years–https://www.medscape.com/viewarticle/990267?src=rss
Side effects?
Just a few https://www.wegovy.com/taking-wegovy/side-effects.html
- Possible thyroid tumors, including cancer.
- Inflammation of your pancreas (pancreatitis)
- Gallbladder problems
- Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin
- Kidney problems (kidney failure)
- Serious allergic reactions
- Change in vision in people with type 2 diabetes.
- Increased heart rate
- Depression or thoughts of suicide.
So if you want to lose weight by taking a GLP-1 receptor agonist remember the risks of side effects including the real possibility of having to take a drug that costs up to $1600.00 a month for the rest of your life.
Good luck with that. This joke’s on you.
As an FYI this drug class is being investigated by the EU for a small number of cases reporting suicidal ideation https://www.latimes.com/business/story/2023-07-10/ozempic-weight-loss-drugs-probed-over-reports-of-suicidal-thoughts.
But we already knew this.
Binge Eating Disorder (BED)
Oklahoma producing 64 times more marijuana than licensed users consume – The Oklahoman
“The supply-to-demand ratio of regulated medical marijuana supply to regulated medical cannabis demand is 64:1,” the report states. “Using a general assumption that units of supply should not exceed two times the units of demand, the medical marijuana program has no less than 32 times more regulated marijuana necessary than licensed patient demand.”
The significant oversupply is likely funneling large amounts of marijuana out of state and adding to the illegal market, according to authority officials.
Oklahoma producing 64 times more marijuana than licensed users consume, report shows — https://www.oklahoman.com/story/news/state/2023/06/21/marijuana-oklahoma-overproducing-64-times-omma-report/70343452007/
The Truth behind the medical marijuana industry.
At least we know there may be a positive longevity effect to all of this excess supply.



You must be logged in to post a comment.